Vir Biotechnology (VIR) Other Operating Expenses (2018 - 2025)

Vir Biotechnology's Other Operating Expenses history runs 7 years deep, the most recent figure standing at $26000.0 for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 100.8% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at -$146000.0 (down 100.41% YoY), while the FY2025 annual figure was -$156000.0, down 100.44% from the prior year.
• Other Operating Expenses came in at $26000.0 for Q4 2025 at Vir Biotechnology, up from -$11000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $90.1 million in Q1 2022 to a low of -$3.3 million in Q4 2024.
• A 5-year average of $13.9 million and a median of $5.4 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses jumped 2340.65% in 2022 and tumbled 190.91% in 2025, its largest moves.
• Vir Biotechnology's Other Operating Expenses stood at $56.9 million in 2021, then plunged by 89.46% to $6.0 million in 2022, then retreated by 6.29% to $5.6 million in 2023, then sank by 158.02% to -$3.3 million in 2024, then jumped by 100.8% to $26000.0 in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $26000.0, -$11000.0, and -$161000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison